Status:
UNKNOWN
Telemedicine Clinic for Prostate Cancer Patients
Lead Sponsor:
Grand River Hospital
Conditions:
Cancer, Treatment-Related
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferenc...
Eligibility Criteria
Inclusion
- Male over 18 years of age with prostate cancer receiving oral treatment with abiraterone or enzalutamide.
- Ability to provide consent to study.
- Willingness to complete study questionnaires and a semi-structured exit interview.
- Adequate command of the English language to complete study questionnaire and survey.
- Access to technology to allow a link to the virtual telemedicine clinic. (excluding control group)
- Willingness to participate in videoconference with pharmacist or nurse from their home environment. (excluding control group)
Exclusion
- Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide.
- Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group)
- \-
Key Trial Info
Start Date :
October 28 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03413865
Start Date
October 28 2016
End Date
June 1 2021
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grand River Hospital
Kitchener, Ontario, Canada